ArticleJournal of virology2025
Respiratory syncytial virus phosphoprotein has NTPase and helicase-like activities.
Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Towards broader-spectrum direct-acting antivirals against RNA viruses.Nature reviews. Microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Respiratory syncytial virus (RSV), a non-segmented, negative-sense RNA virus (NNSV) in the family Pneumoviridae, represents a significant global health burden causing severe lower respiratory tract infections in infants and immunocompromised adults. While RNA helicases are essential for viral replication through their RNA remodeling functions, the presence of such enzymatic activities in RSV remains unclear. Here, we reveal that the RSV phosphoprotein (P), despite lacking canonical helicase motifs, demonstrates nucleoside triphosphatase (NTPase) activity and directional 5'-to-3' RNA helix-unwinding capacity in an NTP-dependent manner. Through mutagenesis assays, we establish a functional coupling between NTP hydrolysis and helicase-like activity. Importantly, reverse genetics experiments, RSV minigenome, and antiviral-effect assays demonstrate the essentiality of RSV P's helicase-like activity for viral viability and replication. These findings identify P as an enzymatic component critical for RSV replication, providing new insights into the mechanisms of pneumovirus propagation. IMPORTANCE: RNA helicases and helicase-like viral proteins are crucial for viral RNA replication and are prime targets for antiviral development. RSV infects nearly all children by age two, causing over 30 million acute lower respiratory infections, 3.6 million hospitalizations, and 100,000 deaths annually in children under five, while also posing a significant threat to immunocompromised adults and the elderly. In this study, we demonstrate for the first time that the RSV P has NTPase activity and unwinds RNA helices in an NTP-dependent manner. Mutagenesis and reverse genetics experiments confirm that these enzymatic activities are essential for RSV viability. These findings not only redefine RSV P as a multifunctional protein but also expand our understanding of the RSV replication machinery, highlighting the potential of targeting P for antiviral therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.